Preliminary Insights Into Early Ambulation and Hemostasis After Atrial Fibrillation Ablation Using the Perclose Vascular Closure Device.

Circulation reports Pub Date : 2024-08-01 eCollection Date: 2024-09-10 DOI:10.1253/circrep.CR-24-0045

Ryuki Chatani, Kota Morikawa, Mitsuru Yoshino, Hiroshi Tasaka, Kazushige Kadota

引用次数: 0

Abstract

Background: The introduction of the Perclose vascular closure device (VCD) for atrial fibrillation (AF) ablation procedures in Japan is expected to facilitate early ambulation.

Methods and results: The study population comprised 554 patients undergoing AF ablation, of whom 377 successfully underwent Perclose VCD deployment at the end of the procedure. At 4 h after the procedure, 94% (353/377 patients) achieved early hemostasis and 57% (213/377 patients) achieved early ambulation. Notably, 0.5% (2/377 patients) developed acute deep vein thrombosis.

Conclusions: The Perclose VCD demonstrated promising efficacy in achieving early hemostasis, potentially facilitating early ambulation and discharge in appropriate patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

使用 Perclose 血管闭合装置进行心房颤动消融术后早期活动和止血的初步见解。

背景：日本在心房颤动（房颤）消融术中引入了Perclose血管闭合装置（VCD），有望促进患者尽早下床活动：研究对象包括 554 名接受房颤消融术的患者，其中 377 人在手术结束时成功安装了 Perclose VCD。术后 4 小时，94% 的患者（353/377 例）实现了早期止血，57% 的患者（213/377 例）实现了早期下床活动。值得注意的是，0.5%（2/377 名患者）发生了急性深静脉血栓：结论：Perclose VCD 在实现早期止血方面具有良好的疗效，可帮助合适的患者尽早康复出院。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Circulation reports

自引率

0.00%

发文量

期刊最新文献

Usefulness of Native T1 in Cardiac Magnetic Resonance Imaging and Echocardiographic Strain Parameters for Detecting Early Cardiac Involvement in Fabry Cardiomyopathy. Effect of Vericiguat on Left Ventricular Reverse Remodeling in Patients Who Have Heart Failure With Reduced Ejection Fraction　- Special Focus on Patients Without Quadruple Medical Therapy. Efficacy of Inspiratory Muscle Training in Patients With Acute Decompensated Heart Failure. Real-World Evidence of Feasible Assessment and Intervention in Cardiovascular Physical Therapy for Older Patients With Heart Failure　- Insight From the J-Proof HF of the Japanese Society of Cardiovascular Physical Therapy. Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection Fraction.